Fucoidan inhibits CCL22 production through NF-kappa B pathway in M2 macrophages: a potential therapeutic strategy for cancer | |
Sun, Jia; Sun, Jintang; Song, Bingfeng; Zhang, Lin; Shao, Qianqian; Liu, Yanguo; Yuan, Daoying; Zhang, Yun; Qu, Xun | |
刊名 | SCIENTIFIC REPORTS |
2016 | |
卷号 | 6 |
DOI | 10.1038/srep35855 |
URL标识 | 查看原文 |
内容类型 | 期刊论文 |
URI标识 | http://www.corc.org.cn/handle/1471x/4688813 |
专题 | 山东大学 |
作者单位 | Shandong Univ, Qilu Hosp, Inst Basic Med Sci, Jinan 250012, |
推荐引用方式 GB/T 7714 | Sun, Jia,Sun, Jintang,Song, Bingfeng,et al. Fucoidan inhibits CCL22 production through NF-kappa B pathway in M2 macrophages: a potential therapeutic strategy for cancer[J]. SCIENTIFIC REPORTS,2016,6. |
APA | Sun, Jia.,Sun, Jintang.,Song, Bingfeng.,Zhang, Lin.,Shao, Qianqian.,...&Qu, Xun.(2016).Fucoidan inhibits CCL22 production through NF-kappa B pathway in M2 macrophages: a potential therapeutic strategy for cancer.SCIENTIFIC REPORTS,6. |
MLA | Sun, Jia,et al."Fucoidan inhibits CCL22 production through NF-kappa B pathway in M2 macrophages: a potential therapeutic strategy for cancer".SCIENTIFIC REPORTS 6(2016). |
个性服务 |
查看访问统计 |
相关权益政策 |
暂无数据 |
收藏/分享 |
除非特别说明,本系统中所有内容都受版权保护,并保留所有权利。
修改评论